Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study
One of the drugs that Oldwick, New Jersey-based Provention Bio joined forces with J&J on has failed a mid-stage study.
The company was testing the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
